The Food and Drug Administration (FDA) is forecasting a new contract opportunity called CDEROne Core, which focuses on business transformation, data management, and operational services related to data analytics, enterprise data warehouse (EDW), and integrity operations. The procurement is categorized under Other Computer Related Services (NAICS 541519) and is expected to have a solicitation release date of March 1, 2026, with an estimated contract award date of May 1, 2026. The project appears to encompass critical data and technology infrastructure supporting the FDA's Center for Drug Evaluation and Research (CDER).

The point of contact for this opportunity is Christopher Scott, who can be reached at christopher.scott@fda.hhs.gov within the Food and Drug Administration organization. While specific award values and detailed performance locations are not currently available in the forecast, the contract seems positioned to support key FDA initiatives including PDUFA (Prescription Drug User Fee Act) and PQCMC (presumably a quality or compliance management component). Interested vendors should prepare comprehensive technical and operational capabilities in data analytics, enterprise data management, and related technological services to be competitive for this federal contract opportunity.

CDEROne Core (Business Transformation, Integrity DME and O&M, PDUFA, PQCMC)

Forecast facts

About this forecast

Forecast text

Work this forecast